Brokerages Anticipate Vitamin Shoppe Inc (VSI) Will Post Earnings of -$0.24 Per Share

Equities research analysts expect that Vitamin Shoppe Inc (NYSE:VSI) will announce earnings of ($0.24) per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Vitamin Shoppe’s earnings, with estimates ranging from ($0.35) to ($0.04). Vitamin Shoppe posted earnings of $0.36 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 166.7%. The firm is scheduled to report its next earnings report before the market opens on Tuesday, February 27th.

On average, analysts expect that Vitamin Shoppe will report full-year earnings of $0.34 per share for the current year, with EPS estimates ranging from $0.22 to $0.52. For the next year, analysts anticipate that the firm will post earnings of $0.31 per share, with EPS estimates ranging from $0.20 to $0.60. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that follow Vitamin Shoppe.

A number of analysts have commented on the company. Barclays decreased their target price on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. ValuEngine downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Morgan Stanley decreased their target price on Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Finally, Zacks Investment Research upgraded Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research report on Sunday, January 21st. Three research analysts have rated the stock with a sell rating and six have assigned a hold rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $5.00.

Shares of Vitamin Shoppe (VSI) opened at $4.10 on Monday. The company has a quick ratio of 0.32, a current ratio of 2.07 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $92.31, a P/E ratio of -0.39 and a beta of 0.59. Vitamin Shoppe has a 12 month low of $2.95 and a 12 month high of $23.25.

In related news, major shareholder Shah Capital Management purchased 300,000 shares of the business’s stock in a transaction dated Monday, February 5th. The stock was bought at an average cost of $3.83 per share, with a total value of $1,149,000.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Vintage Capital Management Llc purchased 326,692 shares of the business’s stock in a transaction dated Friday, January 5th. The stock was bought at an average cost of $4.96 per share, with a total value of $1,620,392.32. The disclosure for this purchase can be found here. Over the last three months, insiders bought 1,000,639 shares of company stock valued at $4,387,647. Insiders own 1.07% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Schwab Charles Investment Management Inc. increased its stake in Vitamin Shoppe by 34.6% in the second quarter. Schwab Charles Investment Management Inc. now owns 262,123 shares of the specialty retailer’s stock valued at $3,054,000 after purchasing an additional 67,362 shares during the last quarter. Nationwide Fund Advisors increased its stake in Vitamin Shoppe by 84.3% in the second quarter. Nationwide Fund Advisors now owns 31,662 shares of the specialty retailer’s stock valued at $369,000 after purchasing an additional 14,478 shares during the last quarter. UBS Asset Management Americas Inc. increased its stake in Vitamin Shoppe by 17,041.4% in the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after purchasing an additional 11,929 shares during the last quarter. FMR LLC increased its stake in Vitamin Shoppe by 32.4% in the second quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock valued at $14,617,000 after purchasing an additional 307,050 shares during the last quarter. Finally, California Public Employees Retirement System increased its stake in Vitamin Shoppe by 37.3% in the second quarter. California Public Employees Retirement System now owns 82,100 shares of the specialty retailer’s stock valued at $956,000 after purchasing an additional 22,300 shares during the last quarter. 99.86% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This story was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://ledgergazette.com/2018/02/15/brokerages-anticipate-vitamin-shoppe-inc-vsi-will-post-earnings-of-0-24-per-share.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Get a free copy of the Zacks research report on Vitamin Shoppe (VSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply